Topchoice Medical (600763.SH) announced its semi-annual report for 2024, achieving revenue of 1.411 billion yuan for the reporting period, a year-on-year increase of 3.52%; net income attributable to shareholders of listed companies was 0.31 billion yuan, a year-on-year increase of 1.77%; net income attributable to shareholders of listed companies excluding non-recurring gains and losses was 0.306 billion yuan, a year-on-year increase of 4.33%; basic earnings per share was 0.97 yuan.
During the reporting period, the company actively promoted the implementation of the operation platform CM Management Center, integrating hospital CM integration CASE management and customer management. By comprehensively collecting and sorting out customer needs, a CASE task list is formed and implemented for doctors and teams, integrating cross-functional and cross-team resources to provide personalized services for customers, solve customer needs in real time, achieve daily clearance, and gradually realize the management and maintenance of customer oral cavity life cycle. With the launch and operation of the digital management system, CASE management will be more efficient and accurate. In terms of medical management, the company has standardized disease types, doctor classification, doctor training, and medical processes, and applied them to the daily work of hospitals, further improving the management, operation, and diagnostic levels of each hospital.